BioArctic
BioArctic: Outlicenses PyroGlutamate-amyloid-beta antibody program to BMS (Redeye)

2024-12-19 08:59
Redeye endorses the news that BioArctic has signed a licensing agreement with BMS regarding BioArctic's PyroGlutamate-amyloid-beta antibody program and give our initial take.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

BioArctic B - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -